Elicio Therapeutics, Inc.
ELTX • NASDAQ
Elicio Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert T. Connelly, with a market cap of $192.1M.
Market Cap$192.1M
Employees32.0
CEORobert T. Connelly
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Elicio Therapeutics, Inc. FAQ
Common questions about Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
Elicio Therapeutics, Inc. has approximately 32 employees.